M
Merete Lund Hetland
Researcher at University of Copenhagen
Publications - 377
Citations - 12397
Merete Lund Hetland is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 55, co-authored 343 publications receiving 10750 citations. Previous affiliations of Merete Lund Hetland include Aalborg University & Rigshospitalet.
Papers
More filters
Journal ArticleDOI
FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries
Axel Finckh,D. Neto,J. Gomez-Reino,Florenzo Iannone,Elisabeth Lie,Helena Canhão,Karel Pavelka,Carl Turesson,Xavier Mariette,J.-E. Gottenberg,Merete Lund Hetland +10 more
TL;DR: The results of this large pooled RA population of mostly inadequate responders to anti-TNFs, suggest that ABA retention and response to ABA treatment are not influenced by csDMARDs cotherapy.
Journal ArticleDOI
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Merete Lund Hetland,Ib Jarle Christensen,Ulrik Tarp,Lene Dreyer,Annette Hansen,Ib Tønder Hansen,Gina Kollerup,Louise Linde,Hanne Merete Lindegaard,Uta Engling Poulsen,Annette Schlemmer,Dorte Vendelbo Jensen,Signe Marie Jensen,Gisela Hostenkamp,Mikkel Østergaard +14 more
TL;DR: Older age, low functional status, and concomitant prednisolone treatment were negative predictors of a clinical response and remission in patients with rheumatoid arthritis.
Journal ArticleDOI
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)
Merete Lund Hetland,Bo Ejbjerg,Kim Hørslev-Petersen,Søren Jacobsen,Aage Vestergaard,A G Jurik,Kristian Stengaard-Pedersen,Peter Junker,Tine Lottenburger,Inger Marie Jensen Hansen,L S Andersen,Ulrik Tarp,Henrik Skjødt,J. K. Pedersen,O Majgaard,Anders Jørgen Svendsen,Torkell Ellingsen,Hanne Merete Lindegaard,Anne Friesgaard Christensen,J. Vallø,Trine Torfing,Eva Narvestad,Henrik S. Thomsen,Mikkel Østergaard +23 more
TL;DR: In a randomised controlled trial aiming at remission in patients with early RA, baseline RAMRIS MRI bone oedema score of MCP and wrist joints (and of wrist only) was the strongest independent predictor of radiographic progression in hands, wrists and forefeet after 2 years.
Journal ArticleDOI
QUEST-RA: Quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries
Tuulikki Sokka,Hannu Kautiainen,Sergui Toloza,Heidi Mäkinen,Suzanne M M Verstappen,Merete Lund Hetland,Antonio Naranjo,Eva Baecklund,G. Herborn,Rolf Rau,M Cazzato,Laure Gossec,Vlado Skakic,Feride Gogus,Stanisław Sierakowski,Barry Bresnihan,Peter C. Taylor,C McClinton,Theodore Pincus +18 more
TL;DR: This international multicentre cross-sectional database provides an overview of clinical status and treatments of patients with RA in standard clinical care in 2005–6 including countries that are infrequently involved in clinical research projects.
Journal ArticleDOI
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
Katerina Chatzidionysiou,Elisabeth Lie,Evgeny Nasonov,Galina Lukina,Merete Lund Hetland,Ulrik Tarp,Cem Gabay,Piet L. C. M. van Riel,Dan Nordström,Juan J. Gomez-Reino,Karel Pavelka,Matija Tomšič,Tore K Kvien,Ronald F van Vollenhoven +13 more
TL;DR: Effectiveness was best when RTX was used as the first biological agent or after failure of no more than one anti-tumour necrosis factor agent and seropositive patients achieved significantly greater reductions in DAS28 at 6 months than seronegative patients.